A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J. van der Lee, Estrella Morenas‐Rodríguez, Iris E. Jansen et al.|Acta Neuropathologica|2019Cited by 132
TREM2 protects from atherosclerosis by limiting necrotic core formationMarie Piollet, Clément Cochain, Florentina Porsch et al.|Nature Cardiovascular Research|2024Cited by 109
Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's diseaseDaniel Alcolea, Juan Fortea, Eduard Vilaplana et al.|Neurobiology of Aging|2015Cited by 91